In summary, the study may enable the development of practical molecular targeted therapies, such as RTKs including EGF receptor family upstream at RAS-MAP-kinase and FAS death receptor merged into the PI3K-PTEN-AKT proapoptotic pathway based on the diagnosis and prognosis in PCNSL. The gene discussed is PIK3CD; the disease is primary central nervous system lymphoma.